From wiki:
Imugene began as a research project in the laboratory of Professor Ursula Wiedermann at the Medical University of Vienna. Over the nine years from 2004 Wiedermann et al. had developed a B cell peptide cancer immunotherapy that could induce an antibody response targeting HER-2 overexpressing tumours. In 2012 a start-up company called Biolife Science had been incorporated to develop this immunotherapy. Early-stage funding was secured from Australian and US investors in 2013, after which Biolife was taken public in December 2013 in a reverse takeover of an Australian drug development company called Imugene, whose name was retained after the merger
Charting Only., page-2349
-
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.002(3.85%) |
Mkt cap ! $396.8M |
Open | High | Low | Value | Volume |
5.2¢ | 5.4¢ | 5.2¢ | $256.1K | 4.874M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 1016165 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 1895555 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 1014632 | 0.053 |
22 | 2134658 | 0.052 |
43 | 4484445 | 0.051 |
70 | 5885827 | 0.050 |
17 | 2472174 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 1895604 | 20 |
0.055 | 1065154 | 13 |
0.056 | 2879641 | 14 |
0.057 | 790110 | 8 |
0.058 | 800800 | 6 |
Last trade - 14.01pm 27/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online